Close

Yuvraj

Eli Lilly to Open a Diabetes-Focused Research Center in China

Eli Lilly and Company announced plans to open a research center focused on diabetes in China, where the incidence of the disease has reached...

Merck’s Investigational Medicine Boceprevir Achieved Significantly Higher SVR Rates

Merck reported that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, demonstrated significantly higher sustained...

GlaxoSmithKline receives approval in Japan from the Ministry of Health

GlaxoSmithKline announced that it has received approval in Japan from the Ministry of Health, Labour and Welfare for Revolade (eltrombopag) for the treatment of...

Nycomed to acquire of majority stake in Guangdong Techpool Bio-Pharma

Nycomed announced that it is significantly expanding its presence in China through the acquisition of a majority stake in Guangdong Techpool Bio-Pharma Co., Ltd....

University of Rochester Spearheads FDA Initiative to Speed Development of New Therapies

Pain is the most common symptom leading patients to see a physician in the United States, yet the most widely prescribed medications – opioids...

Dako and Quintiles form alliance to speed development of personalized medicine

Dako, a Danish-based world leader in tissue-based cancer diagnostics, and Quintiles, the world’s leading bio pharmaceutical services companies, announced a strategic alliance to advance...

GlaxoSmithKline announced third quarter results-Net Sales growth of 14% compared to the previous quarter

GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the third quarter ended 30th September 2010. The Company has posted a Net Sales growth...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read